1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Diastolic Hypertension Global Clinical Trials Review, H2, 2014

Diastolic Hypertension Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Diastolic Hypertension Global Clinical Trials Review, H2, 2014" provides data on the Diastolic Hypertension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diastolic Hypertension. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Diastolic Hypertension. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Diastolic Hypertension Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Diastolic Hypertension 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Diastolic Hypertension to Cardiovascular Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Diastolic Hypertension to Cardiovascular Clinical Trials 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Sponsors 23
Top Companies Participating in Diastolic Hypertension Therapeutics Clinical Trials 24
Prominent Drugs 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
Actavis plc 26
Clinical Trial Overview of Actavis plc 26
Novartis AG 27
Clinical Trial Overview of Novartis AG 27
Theravalues Corporation 28
Clinical Trial Overview of Theravalues Corporation 28
Solvotrin Innovations Ltd 29
Clinical Trial Overview of Solvotrin Innovations Ltd 29
Clinical Trial Overview of Top Institutes / Government 30
Osona Foundation for Research and Health Education 30
Clinical Trial Overview of Osona Foundation for Research and Health Education 30
Hong Kong Health Services Research Fund (China) 31
Clinical Trial Overview of Hong Kong Health Services Research Fund (China) 31
Tottori University Hospital 32
Clinical Trial Overview of Tottori University Hospital 32
Kumamoto University 33
Clinical Trial Overview of Kumamoto University 33
Isfahan University of Medical Sciences 34
Clinical Trial Overview of Isfahan University of Medical Sciences 34
Wayne State University 35
Clinical Trial Overview of Wayne State University 35
St. John's Health System 36
Clinical Trial Overview of St. John's Health System 36
University of Chicago 37
Clinical Trial Overview of University of Chicago 37
Five Key Clinical Profiles 38
Appendix 68
Abbreviations 68
Definitions 68
Research Methodology 69
Secondary Research 69
About GlobalData 70
Contact Us 70
Disclaimer 70
Source 70

List of Tables
Diastolic Hypertension Therapeutics, Global, Clinical Trials by Region, 2014* 6
Diastolic Hypertension Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Diastolic Hypertension Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Diastolic Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Diastolic Hypertension Therapeutics Clinical Trials, Europe, Top Countries, 2014* 10
Diastolic Hypertension Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Diastolic Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Proportion of Diastolic Hypertension to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 13
Diastolic Hypertension Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Diastolic Hypertension Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Diastolic Hypertension to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 16
Diastolic Hypertension Therapeutics, Global, Clinical Trials by Phase, 2014* 17
Diastolic Hypertension Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 18
Diastolic Hypertension Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Diastolic Hypertension Therapeutics Clinical Trials, Global, by End Point Status, 2014* 20
Diastolic Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 21
Diastolic Hypertension Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 22
Diastolic Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 23
Diastolic Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 24
Diastolic Hypertension Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 25
Diastolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2014* 26
Diastolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 27
Diastolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Theravalues Corporation, 2014* 28
Diastolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Solvotrin Innovations Ltd, 2014* 29
Diastolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Osona Foundation for Research and Health Education, 2014* 30
Diastolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Hong Kong Health Services Research Fund (China), 2014* 31
Diastolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Tottori University Hospital, 2014* 32
Diastolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Kumamoto University, 2014* 33
Diastolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Isfahan University of Medical Sciences, 2014* 34
Diastolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Wayne State University, 2014* 35
Diastolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by St. John's Health System, 2014* 36
Diastolic Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Chicago, 2014* 37

List of Figures
Diastolic Hypertension Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Diastolic Hypertension Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Diastolic Hypertension Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Diastolic Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Diastolic Hypertension Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 10
Proportion of Diastolic Hypertension to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 13
Diastolic Hypertension Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Diastolic Hypertension Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Diastolic Hypertension to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 16
Diastolic Hypertension Therapeutics, Global, Clinical Trials by Phase (%), 2014* 17
Diastolic Hypertension Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 18
Diastolic Hypertension Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Diastolic Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 21
Diastolic Hypertension Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 22
Diastolic Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 23
Diastolic Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 24
Diastolic Hypertension Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 25
GlobalData Methodology 69

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.